tm
Seeing Is Believing
tm
Seeing Is Believing
PRME is currently covered by 6 analysts with an average price target of $7.72. This is a potential upside of $3.91 (102.62%) from yesterday's end of day stock price of $3.81.
Prime Medicine's activity chart (see below) currently has 51 price targets and 53 ratings on display. The stock rating distribution of PRME is 77.78% BUY and 22.22% HOLD.
Analysts average stock forecasts to be materialized ratio is 17.8% with an average time for these price targets to be met of 50.36 days.
Highest price target for PRME is $11, Lowest price target is $4.25, average price target is $7.72.
Most recent stock forecast was given by KEAY NAKAE from CHARDAN CAPITAL on 25-Sep-2026. First documented stock forecast 13-Nov-2022.
Currently out of the existing stock ratings of PRME, 7 are a BUY (77.78%), 2 are a HOLD (22.22%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 25-Aug-2026
$7
$3.53 (101.73%)
$7
27 days ago
(25-Sep-2026)
0/2 (0%)
$4.1 (141.38%)
Buy Since 10-Aug-2026
$8
$4.53 (130.55%)
$8
2 months 12 days ago
(10-Aug-2026)
0/9 (0%)
$4.85 (153.97%)
Buy Since 09-Dec-2024
$6
$2.53 (72.91%)
$6
4 months ago
(22-Jun-2026)
2/6 (33.33%)
$2.63 (78.04%)
121
Buy Since 09-Oct-2023
$11
$7.57 (220.70%)
$10
7 months 10 days ago
(12-Mar-2026)
0/3 (0%)
$7.27 (194.91%)
Hold Since 11-Nov-2025
$4.25
$0.82 (23.91%)
11 months 11 days ago
(11-Nov-2025)
1/4 (25%)
$0.33 (8.42%)
29
What is PRME (Prime Medicine) average time for price targets to be met?
Which analyst most recently updated their price target on PRME (Prime Medicine)?
Which analyst has the most public recommendations on PRME (Prime Medicine)?
Which analyst is the currently most bullish on PRME (Prime Medicine)?
Which analyst is the currently most reserved on PRME (Prime Medicine)?
